Yasir B. Al-Wakeel
2016
In 2016, Yasir B. Al-Wakeel earned a total compensation of $848.2K as Former Chief Financial Officer and Head of Corporate Development at Merrimack Pharmaceuticals, a 63% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $129,500 |
|---|---|
| Option Awards | $340,977 |
| Salary | $369,096 |
| Other | $8,636 |
| Total | $848,209 |
Al-Wakeel received $369.1K in salary, accounting for 44% of the total pay in 2016.
Al-Wakeel also received $129.5K in non-equity incentive plan, $341K in option awards and $8.6K in other compensation.
Rankings
In 2016, Yasir B. Al-Wakeel's compensation ranked 9,032nd out of 14,075 executives tracked by ExecPay. In other words, Al-Wakeel earned more than 35.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,032 out of 14,075 | 36th |
Division Manufacturing | 3,490 out of 5,489 | 36th |
Major group Chemicals And Allied Products | 1,195 out of 1,895 | 37th |
Industry group Drugs | 943 out of 1,538 | 39th |
Industry Pharmaceutical Preparations | 751 out of 1,176 | 36th |
Source: SEC filing on June 26, 2017.
Al-Wakeel's colleagues
We found five more compensation records of executives who worked with Yasir B. Al-Wakeel at Merrimack Pharmaceuticals in 2016.
2016
Robert Mulroy
Merrimack Pharmaceuticals
Chief Executive Officer
2016
Edward Stewart
Merrimack Pharmaceuticals
Former Head of Commercial
2016
Peter Laivins
Merrimack Pharmaceuticals
Former Head of Development
2016
William McClements
Merrimack Pharmaceuticals
Former Head of Corporate Operations
2016
Gary Crocker
Merrimack Pharmaceuticals